الفهرس 
Review of LiteratureOnly 14 pages are availabe for public view
 |  | from | 83 |  |  |
| | | from | 83 | | |
Abstract
Sexuality is an important and complex domain in quality of life related studies. Sexual dysfunction is a taboo subject in many countries and may often be responsible for psycho-pathological disturbances. If female sexuality is disturbed, the consequences it might lead to include familial discord and divorce; and reproduction is also affected.
The present study aimed at evaluating and comparing the possible correlations between the effects of different, commonly used contraceptive methods on female sexuality.
This study included 200 healthy married women. They were divided into 3 groups; group I: Included 60 (30%) women using combined hormonal contraceptives (pills and monthly injections), group II: Included 60 (30%) women using progesterone only hormonal contraceptives (pills and injections) and group III: Included 80 (40%) women using non hormonal contraception cupper intra-uterine device (IUD) (non-hormonally medicated), male condoms, spermicidal gel and suppositories.
The FSFI questionnaire was used in this study as; it is a valid and accurate measure of the female sexual function. This questionnaire comprises 19 questions that evaluate six different domains of sexual function including (desire – arousal – lubrication – orgasm – satisfaction and pain). The FSFI score ≤ 26.5 is the cutoff point for women with sexual dysfunction.
The present study provided new insights into the relationship between sexual interest and contraceptive use, among a random sample of Egyptian females.
Our data suggested that the female sexual function is greatly affected by contraceptive use, as 56.5%(more than half) of the participating females who used contraception were at high risk for sexual dysfunction.
Non hormonal contraceptive users reported the highest scores of FSFI regarding; total, desire, arousal, lubrication, orgasm, satisfaction and pain scores with a highly significant difference with scores of women using hormonal contraception.
Although there was significant decrease of FSFI domains, most women were satisfied with their emotional closeness to their partner, with their relationship and with their sex life in general and this is an indicator for the importance of the emotional aspect of women in relation to sex than the physical aspect.
Until recently, little research or attention has focused on female sexual function. As a result, our knowledge and understanding of the anatomy and physiology of the female sexual response and the pathophysiology of female sexual dysfunction is limited. The study of female sexual dysfunction is gradually evolving. Future advances in the evaluation and treatment of female sexual health problems are forthcoming.
In conclusion, contraception is a must and clinicians may be able to predict, and potentially prevent, the discontinuation of effective contraception by carefully assessing and addressing the positive and negative effects of contraception on mood and sexual interest. Our research concluded that non hormonal contraceptives are the safest methods regarding the general health and also the sexual effects but the development of new combined oral contraceptives (COCs) has been directed toward regimens containing the lowest suitable dose of estrogen and using more selective progestogens in order to minimize steroid-associated unfavorable effects. However, further investigations are required to clarify these results.